Adverse events27

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 27

Download this page as JSON

Type	Event	Organ system	Group	Affected	At risk
other	Anxiety	Psychiatric disorders	Double-Blind Treatment Phase Lower Dose Pitolisant	4	20
other	Anxiety	Psychiatric disorders	Double-Blind Treatment Phase Higher Dose Pitolisant	1	22
other	Anxiety	Psychiatric disorders	Double-Blind Treatment Phase Placebo	2	23
other	Irritability	Psychiatric disorders	Double-Blind Treatment Phase Lower Dose Pitolisant	4	20
other	Irritability	Psychiatric disorders	Double-Blind Treatment Phase Higher Dose Pitolisant	1	22
other	Irritability	Psychiatric disorders	Double-Blind Treatment Phase Placebo	1	23
other	Sleep disorder	Psychiatric disorders	Double-Blind Treatment Phase Lower Dose Pitolisant	2	20
other	Sleep disorder	Psychiatric disorders	Double-Blind Treatment Phase Higher Dose Pitolisant	0	22
other	Sleep disorder	Psychiatric disorders	Double-Blind Treatment Phase Placebo	0	23
other	Nasopharyngitis	Infections and infestations	Double-Blind Treatment Phase Lower Dose Pitolisant	2	20
other	Nasopharyngitis	Infections and infestations	Double-Blind Treatment Phase Higher Dose Pitolisant	2	22
other	Nasopharyngitis	Infections and infestations	Double-Blind Treatment Phase Placebo	1	23
other	COVID-19	Infections and infestations	Double-Blind Treatment Phase Lower Dose Pitolisant	0	20
other	COVID-19	Infections and infestations	Double-Blind Treatment Phase Higher Dose Pitolisant	3	22
other	COVID-19	Infections and infestations	Double-Blind Treatment Phase Placebo	2	23
other	Headache	Nervous system disorders	Double-Blind Treatment Phase Lower Dose Pitolisant	3	20
other	Headache	Nervous system disorders	Double-Blind Treatment Phase Higher Dose Pitolisant	2	22
other	Headache	Nervous system disorders	Double-Blind Treatment Phase Placebo	2	23
other	Abdominal pain upper	Gastrointestinal disorders	Double-Blind Treatment Phase Lower Dose Pitolisant	2	20
other	Abdominal pain upper	Gastrointestinal disorders	Double-Blind Treatment Phase Higher Dose Pitolisant	0	22

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04257929/events

API reference For AI assistants

Adverse events27

Sources 3

Read this list from software.